Wadhawa Vivek, Doshi Chirag, Hinduja Manish, Garg Pankaj, Patel Kartik, Mishra Amit, Shah Pratik
Department of Cardiovascular and Thoracic Surgery of the U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ Medical College, Ahmedabad), Gujarat, India.
Department of Research of the U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ Medical College, Ahmedabad), Gujarat, India.
Braz J Cardiovasc Surg. 2017 Jul-Aug;32(4):270-275. doi: 10.21470/1678-9741-2017-0024.
Midline sternotomy is the preferred approach for device migration following transcatheter device closure of ostium secundum atrial septal defect. Results of patients operated for device migration were retrospectively reviewed after transcatheter closure of atrial septal defect.
Among the 643 patients who underwent atrial septal defect with closure device, 15 (2.3%) patients were referred for device retrieval and surgical closure of atrial septal defect. Twelve patients underwent device retrieval and surgical closure of atrial septal defect through right antero-lateral minithoracotomy with femoral cannulation. Three patients were operated through midline sternotomy.
Twelve patients operated through minithoracotomy did not require conversion to sternotomy. Due to device migration to site of difficult access through thoracotomy, cardiac tamponade and hemodynamic instability, respectively, three patients were operated through midline sternotomy. Mean aortic cross-clamp time and cardiopulmonary bypass time were 28.1±17.7 and 58.3±20.4 minutes, respectively. No patient had surgical complication or mortality. Mean intensive care unit and hospital stay were 1.6±0.5 days and 7.1±2.2 days, respectively. Postoperative echocardiography confirmed absence of any residual defect and ventricular dysfunction. In a mean follow-up period of six months, no mortality was observed. All patients were in New York Heart Association class I without wound or vascular complication.
Minithoracotomy with femoral cannulation for cardiopulmonary bypass is a safe-approach for selected group of patients with device migration following transcatheter device closure of atrial septal defect without increasing the risk of cardiac, vascular or neurological complications and with good cosmetic and surgical results.
经导管封堵继发孔型房间隔缺损后,若发生封堵器移位,正中胸骨切开术是首选的处理方法。对经导管封堵房间隔缺损后因封堵器移位而接受手术治疗的患者结果进行回顾性分析。
在643例行房间隔缺损封堵器置入术的患者中,15例(2.3%)因封堵器移位需取出封堵器并接受房间隔缺损的外科手术治疗。12例患者通过右前外侧小切口开胸并股动脉插管进行封堵器取出及房间隔缺损外科修补术。3例患者采用正中胸骨切开术。
12例行小切口开胸手术的患者无需转为胸骨切开术。分别由于封堵器移位至开胸手术难以到达的部位、心脏压塞和血流动力学不稳定,3例患者采用正中胸骨切开术。平均主动脉阻断时间和体外循环时间分别为28.1±17.7分钟和58.3±20.4分钟。无患者发生手术并发症或死亡。平均重症监护病房停留时间和住院时间分别为1.6±0.5天和7.1±2.2天。术后超声心动图证实无残余缺损及心室功能障碍。平均随访6个月,无死亡病例。所有患者纽约心脏协会心功能分级均为I级,无伤口或血管并发症。
对于经导管封堵房间隔缺损后发生封堵器移位的部分患者,采用股动脉插管体外循环下小切口开胸手术是一种安全的方法,不会增加心脏、血管或神经并发症的风险,且美容及手术效果良好。